Why Older People May Not Need to Watch Blood Sugar So Closely
Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...
Endocrinology Advisor2d
Baqsimi Approved for Severe Hypoglycemia Treatment in Younger Patients
The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.
Endocrinology Advisor1d
Glargine U300 Safe in Across All CKD Stages in Type 2 Diabetes
Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.
Physician's Weekly10d
Continuous Glucose Monitoring and Glycemic Control After Discharge
The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in ...
Monthly Prescribing Reference4d
Baqsimi Approved for Severe Hypoglycemia Treatment in Younger Patients
The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.